Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges by Nechama Kalter, Carla Fuster-García, Alfredo Silva, Víctor Ronco-Díaz, Stefano Roncelli, Giandomenico Turchiano, Jan Gorodkin, Toni Cathomen, Karim Benabdellah, Ciaran Lee, Ayal Hendel

Get full text

Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years by Lúcia Mamede, Roser Cantenys Sabà, Roser Cantenys Sabà, Samya Van Coillie, Johan Prévot, Silvia Sánchez-Ramón, Cecilia Poli, Cecilia Poli, Cecilia Poli, Anne Barasa, Björn W. Schuller, Björn W. Schuller, Björn W. Schuller, Ayal Hendel, Nicolas Garcelon, Cornelis Boersma, Cornelis Boersma, Cornelis Boersma, Pamela Lee, Claire Booth, Claire Booth, Luigi D. Notarangelo, Jose Drabwell, Nicholas L. Rider, Frank J. T. Staal, Frank J. T. Staal, Siobhan O. Burns, Siobhan O. Burns, Martin Van Hagen, Martin Van Hagen, Martin Van Hagen, Martine Pergent, Jacques G. Rivière, Jacques G. Rivière, Jacques G. Rivière, Jacques G. Rivière, Nizar Mahlaoui, Nizar Mahlaoui, Nizar Mahlaoui

Get full text